A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02886715. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT02886715
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Fougera Pharmaceuticals Inc.
- Industry
- Enrollment
- 1,110 participants
Conditions and interventions
Conditions
Interventions
- Tazarotene Cream 0.1% Drug
- Tazorac® Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 20, 2016
- Primary completion
- May 30, 2017
- Completion
- May 30, 2017
- Last update posted
- Aug 16, 2018
2016 – 2017
United States locations
- U.S. sites
- 25
- U.S. states
- 9
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fougera Investigational Site | Tucson | Arizona | 85712 | — |
| Fougera Investigational Site | Conway | Arkansas | 72034 | — |
| Fougera Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Fougera Investigational Site | Anaheim | California | 92801 | — |
| Fougera Investigational Site | La Mesa | California | 91942 | — |
| Fougera Investigational Site | Long Beach | California | 90806 | — |
| Fougera Investigational Site | Long Beach | California | 90813 | — |
| Fougera Investigational Site | Los Angeles | California | 90010 | — |
| Fougera Investigational Site | North Hollywood | California | 91606 | — |
| Fougera Investigational Site | San Diego | California | 92108 | — |
| Fougera Investigational Site | San Ramon | California | 94582 | — |
| Fougera Investigational Site | Upland | California | 91786 | — |
| Fougera Investigational Site | West Covina | California | 91790 | — |
| Fougera Investigational Site | Coral Gables | Florida | 33134 | — |
| Fougera Investigational Site | Miami | Florida | 33015 | — |
| Fougera Investigational Site | Miami | Florida | 33175 | — |
| Fougera Investigational Site | Miami Gardens | Florida | 33169 | — |
| Fougera Investigational Site | Miramar | Florida | 33027 | — |
| Fougera Investigational Site | Sweetwater | Florida | 33172 | — |
| Fougera Investigational Site | Plainfield | Indiana | 46168 | — |
| Fougera Investigational Site | High Point | North Carolina | 27262 | — |
| Fougera Investigational Site | Hazleton | Pennsylvania | 18201 | — |
| Fougera Investigational Site | Upper Saint Clair | Pennsylvania | 15241 | — |
| Fougera Investigational Site | Chattanooga | Tennessee | 37421 | — |
| Fougera Investigational Site | Austin | Texas | 78759 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02886715, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02886715 live on ClinicalTrials.gov.